For many development teams, the key question is no longer whether IVBE can work, but how early it should be integrated into the program to have a tangible impact on risk, timelines, and cost.<\/p>\n
These questions and factors were at the core of a presentation by our Head of Biologics Department, Milan Mad\u011bra, delivered to our clients at Conscio Science Day in Munich.<\/p>\n
In the PDF document below, we bring you a snapshot that outlines how we approach IVBE for locally acting drug products, from smart analytical design to robust data evaluation aligned with regulatory expectations.<\/p>\n
By browsing the slides, you will see:<\/p>\n
how IVBE can reshape your development roadmap in terms of both timelines and budget,<\/p>\n<\/li>\n
how different in vitro tools can be integrated into a coherent IVBE strategy,<\/p>\n<\/li>\n
why rigorous method development and validation are essential for a successful submission.<\/p>\n<\/li>\n<\/ul>\n
All concepts are drawn from our day-to-day work at Quinta-Analytica (a Conscio Group<\/a> company) and are meant to serve as inspiration and a benchmark for your own development strategy.<\/p>\n Download the IVBE Analytical Tools for Chemical Research PDF<\/span><\/strong><\/a><\/p>\n
\n